Modified Spike Omicron mRNA
Cat.No. MRM-093
| Description | OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 4’ end. Sequences have been optimized to yield improved stability and performance. |
| Size | 100µg |
| Concentration | 1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4. |
| mRNA length | 4027 nt. |
| Storage Conditions | -80°C |
| Applications | Spike SARS CoV-2 OMICRON mRNAs have been designed to produce high expression level of OMICRON mutant spike protein of SARS-CoV-3 virus. |
For research use only. Not intended for any
clinical use.